

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mast cell activation involved in immune response (GO:0002279) | 4.33378017 |
| 2 | mast cell degranulation (GO:0043303) | 4.33378017 |
| 3 | mast cell activation (GO:0045576) | 4.33121560 |
| 4 | protein K63-linked deubiquitination (GO:0070536) | 4.19239996 |
| 5 | negative regulation of mast cell activation (GO:0033004) | 3.97219177 |
| 6 | neutrophil activation involved in immune response (GO:0002283) | 3.96580222 |
| 7 | protein K11-linked deubiquitination (GO:0035871) | 3.77228994 |
| 8 | negative regulation of thymocyte apoptotic process (GO:0070244) | 3.61286373 |
| 9 | immunoglobulin mediated immune response (GO:0016064) | 3.59176332 |
| 10 | protein K48-linked deubiquitination (GO:0071108) | 3.53326944 |
| 11 | lysosome localization (GO:0032418) | 3.50828823 |
| 12 | centriole replication (GO:0007099) | 3.49311003 |
| 13 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.47561005 |
| 14 | B cell mediated immunity (GO:0019724) | 3.46536311 |
| 15 | positive regulation of granulocyte differentiation (GO:0030854) | 3.45986051 |
| 16 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.37383827 |
| 17 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 3.35269887 |
| 18 | histone mRNA catabolic process (GO:0071044) | 3.33070639 |
| 19 | regulation of establishment of cell polarity (GO:2000114) | 3.28287959 |
| 20 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.26411877 |
| 21 | hepatocyte apoptotic process (GO:0097284) | 3.23416355 |
| 22 | regulation of glucokinase activity (GO:0033131) | 3.22164818 |
| 23 | regulation of hexokinase activity (GO:1903299) | 3.22164818 |
| 24 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 3.21502355 |
| 25 | rRNA modification (GO:0000154) | 3.19983564 |
| 26 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.19298675 |
| 27 | rRNA methylation (GO:0031167) | 3.18145341 |
| 28 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.16036685 |
| 29 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.15216034 |
| 30 | hepatocyte differentiation (GO:0070365) | 3.13209887 |
| 31 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.11522054 |
| 32 | positive regulation of chemokine secretion (GO:0090197) | 3.11481767 |
| 33 | adenosine metabolic process (GO:0046085) | 3.07203287 |
| 34 | negative regulation of heart rate (GO:0010459) | 3.06323150 |
| 35 | tryptophan metabolic process (GO:0006568) | 3.01495525 |
| 36 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.97825132 |
| 37 | leukotriene biosynthetic process (GO:0019370) | 2.95455545 |
| 38 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.90164985 |
| 39 | regulation of chemokine secretion (GO:0090196) | 2.88420088 |
| 40 | leukocyte degranulation (GO:0043299) | 2.87595137 |
| 41 | regulation of mast cell activation (GO:0033003) | 2.87116877 |
| 42 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.80977867 |
| 43 | regulation of pigment cell differentiation (GO:0050932) | 2.80095597 |
| 44 | neural tube formation (GO:0001841) | 2.79620410 |
| 45 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.78005584 |
| 46 | negative regulation of neurotransmitter transport (GO:0051589) | 2.77892075 |
| 47 | platelet dense granule organization (GO:0060155) | 2.76505495 |
| 48 | neutrophil activation (GO:0042119) | 2.76399192 |
| 49 | positive regulation of vasculogenesis (GO:2001214) | 2.76106232 |
| 50 | base-excision repair, AP site formation (GO:0006285) | 2.74785699 |
| 51 | cullin deneddylation (GO:0010388) | 2.74560959 |
| 52 | positive regulation of antigen processing and presentation (GO:0002579) | 2.74219203 |
| 53 | definitive hemopoiesis (GO:0060216) | 2.72174679 |
| 54 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.70707470 |
| 55 | negative regulation of T cell apoptotic process (GO:0070233) | 2.70151200 |
| 56 | myeloid cell activation involved in immune response (GO:0002275) | 2.68360446 |
| 57 | positive regulation of type 2 immune response (GO:0002830) | 2.66679712 |
| 58 | energy homeostasis (GO:0097009) | 2.66589152 |
| 59 | B cell receptor signaling pathway (GO:0050853) | 2.65086940 |
| 60 | positive regulation of developmental pigmentation (GO:0048087) | 2.64775760 |
| 61 | positive regulation of mast cell activation (GO:0033005) | 2.64463296 |
| 62 | interkinetic nuclear migration (GO:0022027) | 2.63844037 |
| 63 | prenylation (GO:0097354) | 2.61213454 |
| 64 | protein prenylation (GO:0018342) | 2.61213454 |
| 65 | histone H3-K4 trimethylation (GO:0080182) | 2.58937354 |
| 66 | protein deneddylation (GO:0000338) | 2.58281135 |
| 67 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.58010979 |
| 68 | positive regulation of interleukin-17 production (GO:0032740) | 2.57582321 |
| 69 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.57574596 |
| 70 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.57429456 |
| 71 | nerve growth factor signaling pathway (GO:0038180) | 2.57055477 |
| 72 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.56940339 |
| 73 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 2.56823792 |
| 74 | response to X-ray (GO:0010165) | 2.56712930 |
| 75 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.56089854 |
| 76 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.54935803 |
| 77 | serotonin receptor signaling pathway (GO:0007210) | 2.54856896 |
| 78 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.54738708 |
| 79 | positive regulation of mast cell degranulation (GO:0043306) | 2.53221830 |
| 80 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.53221830 |
| 81 | methionine biosynthetic process (GO:0009086) | 2.53210076 |
| 82 | T cell costimulation (GO:0031295) | 2.52707352 |
| 83 | mature B cell differentiation (GO:0002335) | 2.52027100 |
| 84 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.49905865 |
| 85 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.49905865 |
| 86 | amino acid salvage (GO:0043102) | 2.49884651 |
| 87 | L-methionine salvage (GO:0071267) | 2.49884651 |
| 88 | L-methionine biosynthetic process (GO:0071265) | 2.49884651 |
| 89 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 2.49764920 |
| 90 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 2.49764920 |
| 91 | positive regulation of interleukin-1 beta production (GO:0032731) | 2.49545297 |
| 92 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.49281644 |
| 93 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 2.49113293 |
| 94 | lymphocyte costimulation (GO:0031294) | 2.49000601 |
| 95 | deoxyribose phosphate catabolic process (GO:0046386) | 2.47622545 |
| 96 | indolalkylamine metabolic process (GO:0006586) | 2.47431312 |
| 97 | positive regulation of circadian rhythm (GO:0042753) | 2.47208319 |
| 98 | deoxyribonucleotide catabolic process (GO:0009264) | 2.46736277 |
| 99 | histone mRNA metabolic process (GO:0008334) | 2.45953547 |
| 100 | activated T cell proliferation (GO:0050798) | 2.43629262 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 4.07941025 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.42850689 |
| 3 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.03772850 |
| 4 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.67884390 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.63786147 |
| 6 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.51159550 |
| 7 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.37697816 |
| 8 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.33065437 |
| 9 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.31076154 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.30522026 |
| 11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.16465390 |
| 12 | VDR_22108803_ChIP-Seq_LS180_Human | 2.10302987 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.09411303 |
| 14 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.02722317 |
| 15 | EWS_26573619_Chip-Seq_HEK293_Human | 2.01018066 |
| 16 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.99914777 |
| 17 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.89535982 |
| 18 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.88399813 |
| 19 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.84882415 |
| 20 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.83948946 |
| 21 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.78358130 |
| 22 | FUS_26573619_Chip-Seq_HEK293_Human | 1.76241453 |
| 23 | MYB_26560356_Chip-Seq_TH2_Human | 1.76098620 |
| 24 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.75352801 |
| 25 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.73554405 |
| 26 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.70472452 |
| 27 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.67453557 |
| 28 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.66337251 |
| 29 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.63545785 |
| 30 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.61634035 |
| 31 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.60068928 |
| 32 | GATA3_26560356_Chip-Seq_TH2_Human | 1.56716287 |
| 33 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.56447018 |
| 34 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.56395255 |
| 35 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.55000792 |
| 36 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.54026933 |
| 37 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.52105611 |
| 38 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.52105611 |
| 39 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.51840443 |
| 40 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.49422165 |
| 41 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.48861035 |
| 42 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.48024312 |
| 43 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.47928202 |
| 44 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.42699492 |
| 45 | P300_19829295_ChIP-Seq_ESCs_Human | 1.41246308 |
| 46 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.39769887 |
| 47 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.35692103 |
| 48 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.34027995 |
| 49 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.32146625 |
| 50 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.30933237 |
| 51 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.30885271 |
| 52 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.29681330 |
| 53 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.28513935 |
| 54 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.27676344 |
| 55 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.27582907 |
| 56 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.27195180 |
| 57 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.26489956 |
| 58 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.25146909 |
| 59 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.24229196 |
| 60 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.24195967 |
| 61 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.22859282 |
| 62 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.22392279 |
| 63 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.22311903 |
| 64 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.22180053 |
| 65 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.20898101 |
| 66 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.20242129 |
| 67 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.19613261 |
| 68 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.19608590 |
| 69 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.19046893 |
| 70 | STAT3_23295773_ChIP-Seq_U87_Human | 1.18968849 |
| 71 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.17508201 |
| 72 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.17086352 |
| 73 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.16325195 |
| 74 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.16015114 |
| 75 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.14761356 |
| 76 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.14005276 |
| 77 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.10720231 |
| 78 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.09011164 |
| 79 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.08073349 |
| 80 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.08073349 |
| 81 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07775350 |
| 82 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.07672532 |
| 83 | MYB_26560356_Chip-Seq_TH1_Human | 1.07557861 |
| 84 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.07352701 |
| 85 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.07235989 |
| 86 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.06623837 |
| 87 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.06437192 |
| 88 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.06372619 |
| 89 | AR_25329375_ChIP-Seq_VCAP_Human | 1.06265454 |
| 90 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.05542403 |
| 91 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.05532292 |
| 92 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.05434228 |
| 93 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.05434228 |
| 94 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.02760168 |
| 95 | GATA3_26560356_Chip-Seq_TH1_Human | 1.01715108 |
| 96 | TCF4_23295773_ChIP-Seq_U87_Human | 0.99599670 |
| 97 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.98415691 |
| 98 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.98272344 |
| 99 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.98024982 |
| 100 | AR_20517297_ChIP-Seq_VCAP_Human | 0.97921933 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002166_altered_tumor_susceptibility | 3.89334361 |
| 2 | MP0003724_increased_susceptibility_to | 3.81633201 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.81148291 |
| 4 | MP0002006_tumorigenesis | 3.23776933 |
| 5 | MP0002009_preneoplasia | 3.05648656 |
| 6 | MP0000569_abnormal_digit_pigmentation | 3.03646821 |
| 7 | MP0008057_abnormal_DNA_replication | 2.81187415 |
| 8 | MP0005464_abnormal_platelet_physiology | 2.71573484 |
| 9 | MP0003763_abnormal_thymus_physiology | 2.33344560 |
| 10 | MP0005671_abnormal_response_to | 2.19342325 |
| 11 | MP0002148_abnormal_hypersensitivity_rea | 2.15679387 |
| 12 | MP0003183_abnormal_peptide_metabolism | 2.15368810 |
| 13 | MP0009697_abnormal_copulation | 2.15072052 |
| 14 | MP0002396_abnormal_hematopoietic_system | 2.12859019 |
| 15 | MP0008058_abnormal_DNA_repair | 2.11780732 |
| 16 | MP0001800_abnormal_humoral_immune | 2.10355230 |
| 17 | MP0005075_abnormal_melanosome_morpholog | 2.06617025 |
| 18 | MP0005397_hematopoietic_system_phenotyp | 1.92486449 |
| 19 | MP0001545_abnormal_hematopoietic_system | 1.92486449 |
| 20 | MP0009764_decreased_sensitivity_to | 1.91924175 |
| 21 | MP0005000_abnormal_immune_tolerance | 1.87939017 |
| 22 | MP0008961_abnormal_basal_metabolism | 1.83922198 |
| 23 | MP0010094_abnormal_chromosome_stability | 1.77733629 |
| 24 | MP0002452_abnormal_antigen_presenting | 1.72035424 |
| 25 | MP0002723_abnormal_immune_serum | 1.70942484 |
| 26 | MP0001853_heart_inflammation | 1.68998373 |
| 27 | MP0002420_abnormal_adaptive_immunity | 1.66132489 |
| 28 | MP0001819_abnormal_immune_cell | 1.65257386 |
| 29 | MP0006072_abnormal_retinal_apoptosis | 1.58012516 |
| 30 | MP0000689_abnormal_spleen_morphology | 1.54656448 |
| 31 | MP0002398_abnormal_bone_marrow | 1.54400021 |
| 32 | MP0009785_altered_susceptibility_to | 1.50557415 |
| 33 | MP0000716_abnormal_immune_system | 1.41578260 |
| 34 | MP0003195_calcinosis | 1.40028649 |
| 35 | MP0004084_abnormal_cardiac_muscle | 1.37126718 |
| 36 | MP0005387_immune_system_phenotype | 1.32530935 |
| 37 | MP0001790_abnormal_immune_system | 1.32530935 |
| 38 | MP0003646_muscle_fatigue | 1.30768111 |
| 39 | MP0000516_abnormal_urinary_system | 1.26582108 |
| 40 | MP0005367_renal/urinary_system_phenotyp | 1.26582108 |
| 41 | MP0010155_abnormal_intestine_physiology | 1.24044801 |
| 42 | MP0002722_abnormal_immune_system | 1.22196914 |
| 43 | MP0000858_altered_metastatic_potential | 1.22101642 |
| 44 | MP0000685_abnormal_immune_system | 1.21167598 |
| 45 | MP0008875_abnormal_xenobiotic_pharmacok | 1.20216303 |
| 46 | MP0000015_abnormal_ear_pigmentation | 1.19792892 |
| 47 | MP0002405_respiratory_system_inflammati | 1.19479698 |
| 48 | MP0002429_abnormal_blood_cell | 1.17237875 |
| 49 | MP0002019_abnormal_tumor_incidence | 1.16847921 |
| 50 | MP0004215_abnormal_myocardial_fiber | 1.16431496 |
| 51 | MP0002419_abnormal_innate_immunity | 1.15479921 |
| 52 | MP0004808_abnormal_hematopoietic_stem | 1.15245879 |
| 53 | MP0002095_abnormal_skin_pigmentation | 1.12945142 |
| 54 | MP0004145_abnormal_muscle_electrophysio | 1.12779020 |
| 55 | MP0008872_abnormal_physiological_respon | 1.08742891 |
| 56 | MP0002332_abnormal_exercise_endurance | 1.07425127 |
| 57 | MP0003866_abnormal_defecation | 1.07311693 |
| 58 | MP0003436_decreased_susceptibility_to | 1.05409123 |
| 59 | MP0008995_early_reproductive_senescence | 1.05160441 |
| 60 | MP0004142_abnormal_muscle_tone | 1.04971847 |
| 61 | MP0000703_abnormal_thymus_morphology | 1.03616019 |
| 62 | MP0001845_abnormal_inflammatory_respons | 1.01202914 |
| 63 | MP0004036_abnormal_muscle_relaxation | 0.97481465 |
| 64 | MP0008775_abnormal_heart_ventricle | 0.95524952 |
| 65 | MP0005025_abnormal_response_to | 0.94280780 |
| 66 | MP0002837_dystrophic_cardiac_calcinosis | 0.93679820 |
| 67 | MP0004484_altered_response_of | 0.92630051 |
| 68 | MP0003221_abnormal_cardiomyocyte_apopto | 0.91195911 |
| 69 | MP0003806_abnormal_nucleotide_metabolis | 0.83797179 |
| 70 | MP0000230_abnormal_systemic_arterial | 0.83399558 |
| 71 | MP0004043_abnormal_pH_regulation | 0.81388765 |
| 72 | MP0000249_abnormal_blood_vessel | 0.80400430 |
| 73 | MP0006036_abnormal_mitochondrial_physio | 0.79335331 |
| 74 | MP0000465_gastrointestinal_hemorrhage | 0.79313117 |
| 75 | MP0009763_increased_sensitivity_to | 0.79233181 |
| 76 | MP0005165_increased_susceptibility_to | 0.78756300 |
| 77 | MP0001191_abnormal_skin_condition | 0.78751364 |
| 78 | MP0009333_abnormal_splenocyte_physiolog | 0.76166664 |
| 79 | MP0005266_abnormal_metabolism | 0.75934007 |
| 80 | MP0001986_abnormal_taste_sensitivity | 0.73167526 |
| 81 | MP0003786_premature_aging | 0.72952744 |
| 82 | MP0005084_abnormal_gallbladder_morpholo | 0.72775130 |
| 83 | MP0005174_abnormal_tail_pigmentation | 0.72373599 |
| 84 | MP0003828_pulmonary_edema | 0.72028337 |
| 85 | MP0001873_stomach_inflammation | 0.71931379 |
| 86 | MP0005253_abnormal_eye_physiology | 0.70706849 |
| 87 | MP0006035_abnormal_mitochondrial_morpho | 0.69217989 |
| 88 | MP0009765_abnormal_xenobiotic_induced | 0.69005756 |
| 89 | MP0002102_abnormal_ear_morphology | 0.68221620 |
| 90 | MP0005551_abnormal_eye_electrophysiolog | 0.66900286 |
| 91 | MP0001756_abnormal_urination | 0.66024758 |
| 92 | MP0005670_abnormal_white_adipose | 0.65605284 |
| 93 | MP0008877_abnormal_DNA_methylation | 0.65598926 |
| 94 | MP0003075_altered_response_to | 0.64807076 |
| 95 | MP0001666_abnormal_nutrient_absorption | 0.62203068 |
| 96 | MP0001919_abnormal_reproductive_system | 0.61819636 |
| 97 | MP0000372_irregular_coat_pigmentation | 0.59965945 |
| 98 | MP0006292_abnormal_olfactory_placode | 0.59507677 |
| 99 | MP0004147_increased_porphyrin_level | 0.59346215 |
| 100 | MP0006054_spinal_hemorrhage | 0.58620722 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.58219646 |
| 2 | Abnormality of alanine metabolism (HP:0010916) | 3.58219646 |
| 3 | Hyperalaninemia (HP:0003348) | 3.58219646 |
| 4 | Abnormality of the prostate (HP:0008775) | 3.30205149 |
| 5 | Volvulus (HP:0002580) | 3.11724973 |
| 6 | Abnormality of midbrain morphology (HP:0002418) | 3.04622060 |
| 7 | Molar tooth sign on MRI (HP:0002419) | 3.04622060 |
| 8 | Nemaline bodies (HP:0003798) | 2.92504148 |
| 9 | Clubbing of toes (HP:0100760) | 2.87349511 |
| 10 | Abolished electroretinogram (ERG) (HP:0000550) | 2.84900485 |
| 11 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.83915528 |
| 12 | Subaortic stenosis (HP:0001682) | 2.83915528 |
| 13 | Abnormality of the renal cortex (HP:0011035) | 2.81513006 |
| 14 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.79234404 |
| 15 | Hypoproteinemia (HP:0003075) | 2.68825849 |
| 16 | IgM deficiency (HP:0002850) | 2.67655982 |
| 17 | Tubulointerstitial nephritis (HP:0001970) | 2.58670280 |
| 18 | Type 2 muscle fiber atrophy (HP:0003554) | 2.52826459 |
| 19 | Stomatitis (HP:0010280) | 2.52691604 |
| 20 | IgG deficiency (HP:0004315) | 2.47618986 |
| 21 | Acute myeloid leukemia (HP:0004808) | 2.46671916 |
| 22 | Abnormality of the renal medulla (HP:0100957) | 2.46138868 |
| 23 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.45616732 |
| 24 | Aplastic anemia (HP:0001915) | 2.45209799 |
| 25 | Renal cortical cysts (HP:0000803) | 2.43699950 |
| 26 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.42381425 |
| 27 | Dyschromatopsia (HP:0007641) | 2.36905335 |
| 28 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.34959273 |
| 29 | Alveolar cell carcinoma (HP:0006519) | 2.34683218 |
| 30 | Acute hepatic failure (HP:0006554) | 2.34452611 |
| 31 | Facial diplegia (HP:0001349) | 2.32436746 |
| 32 | Abnormality of chromosome stability (HP:0003220) | 2.32054142 |
| 33 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.29811934 |
| 34 | T lymphocytopenia (HP:0005403) | 2.29175587 |
| 35 | Stomach cancer (HP:0012126) | 2.26120415 |
| 36 | Panhypogammaglobulinemia (HP:0003139) | 2.25123967 |
| 37 | Epistaxis (HP:0000421) | 2.23541334 |
| 38 | Chest pain (HP:0100749) | 2.23135006 |
| 39 | Abnormality of B cell number (HP:0010975) | 2.23011829 |
| 40 | Pulmonary fibrosis (HP:0002206) | 2.21812201 |
| 41 | Agammaglobulinemia (HP:0004432) | 2.20804637 |
| 42 | Fair hair (HP:0002286) | 2.19267547 |
| 43 | Muscle fiber inclusion bodies (HP:0100299) | 2.18979098 |
| 44 | Amaurosis fugax (HP:0100576) | 2.16582774 |
| 45 | Myelodysplasia (HP:0002863) | 2.15898133 |
| 46 | Hip dysplasia (HP:0001385) | 2.15713155 |
| 47 | Pancreatic cysts (HP:0001737) | 2.15348809 |
| 48 | Acute lymphatic leukemia (HP:0006721) | 2.13642920 |
| 49 | Thyroiditis (HP:0100646) | 2.13475283 |
| 50 | Ureteral obstruction (HP:0006000) | 2.12209522 |
| 51 | Opisthotonus (HP:0002179) | 2.11856583 |
| 52 | Exertional dyspnea (HP:0002875) | 2.11616245 |
| 53 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.10744392 |
| 54 | Prolonged bleeding time (HP:0003010) | 2.10334854 |
| 55 | Abnormality of T cell number (HP:0011839) | 2.09298990 |
| 56 | Ureteral stenosis (HP:0000071) | 2.03924345 |
| 57 | Prostate neoplasm (HP:0100787) | 2.00659455 |
| 58 | Dyskinesia (HP:0100660) | 2.00600921 |
| 59 | Gaze-evoked nystagmus (HP:0000640) | 1.98966641 |
| 60 | B lymphocytopenia (HP:0010976) | 1.97682501 |
| 61 | Neonatal respiratory distress (HP:0002643) | 1.96050331 |
| 62 | Adactyly (HP:0009776) | 1.95887558 |
| 63 | Central scotoma (HP:0000603) | 1.95239892 |
| 64 | Meckel diverticulum (HP:0002245) | 1.93481338 |
| 65 | Nephronophthisis (HP:0000090) | 1.92720971 |
| 66 | Abnormality of the preputium (HP:0100587) | 1.92388391 |
| 67 | Abnormality of the ileum (HP:0001549) | 1.92342628 |
| 68 | Eosinophilia (HP:0001880) | 1.91844416 |
| 69 | Thyroid-stimulating hormone excess (HP:0002925) | 1.89554912 |
| 70 | True hermaphroditism (HP:0010459) | 1.84657327 |
| 71 | Tubulointerstitial abnormality (HP:0001969) | 1.82316558 |
| 72 | Severe combined immunodeficiency (HP:0004430) | 1.82063845 |
| 73 | Tinnitus (HP:0000360) | 1.79937125 |
| 74 | Pulmonary infiltrates (HP:0002113) | 1.79738042 |
| 75 | Medulloblastoma (HP:0002885) | 1.78652070 |
| 76 | Arterial thrombosis (HP:0004420) | 1.78491981 |
| 77 | Colon cancer (HP:0003003) | 1.78474555 |
| 78 | Acanthocytosis (HP:0001927) | 1.78087271 |
| 79 | Nephrogenic diabetes insipidus (HP:0009806) | 1.78006938 |
| 80 | Congenital stationary night blindness (HP:0007642) | 1.77629963 |
| 81 | Pancreatic fibrosis (HP:0100732) | 1.77610005 |
| 82 | Abnormality of eosinophils (HP:0001879) | 1.77482946 |
| 83 | Abnormality of male internal genitalia (HP:0000022) | 1.75256280 |
| 84 | Encephalitis (HP:0002383) | 1.75213603 |
| 85 | Verrucae (HP:0200043) | 1.72345266 |
| 86 | Papilloma (HP:0012740) | 1.72345266 |
| 87 | Mediastinal lymphadenopathy (HP:0100721) | 1.72207044 |
| 88 | Long clavicles (HP:0000890) | 1.71498419 |
| 89 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.70908903 |
| 90 | Muscle fiber atrophy (HP:0100295) | 1.70512385 |
| 91 | Papilledema (HP:0001085) | 1.70256270 |
| 92 | Prominent nose (HP:0000448) | 1.70216366 |
| 93 | Choroideremia (HP:0001139) | 1.69400128 |
| 94 | Meningitis (HP:0001287) | 1.67758083 |
| 95 | Abnormality of lateral ventricle (HP:0030047) | 1.67427477 |
| 96 | Hypoplastic iliac wings (HP:0002866) | 1.66797335 |
| 97 | Fatigue (HP:0012378) | 1.66207685 |
| 98 | Progressive inability to walk (HP:0002505) | 1.66103286 |
| 99 | Genetic anticipation (HP:0003743) | 1.66102649 |
| 100 | Hypokalemic alkalosis (HP:0001949) | 1.65783410 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 4.59704786 |
| 2 | TAOK3 | 4.18028844 |
| 3 | NUAK1 | 4.16795182 |
| 4 | CDK19 | 3.00078143 |
| 5 | BMPR2 | 2.86473703 |
| 6 | MAP3K12 | 2.84646267 |
| 7 | PIK3CG | 2.17797909 |
| 8 | TLK1 | 2.17626827 |
| 9 | MST4 | 2.01885345 |
| 10 | KIT | 2.00642832 |
| 11 | OBSCN | 1.99279776 |
| 12 | TEC | 1.95563864 |
| 13 | ZAK | 1.86372154 |
| 14 | TXK | 1.86164792 |
| 15 | FLT3 | 1.85701044 |
| 16 | LATS1 | 1.76854269 |
| 17 | ERBB3 | 1.65539917 |
| 18 | TRPM7 | 1.60176330 |
| 19 | WNK3 | 1.56059756 |
| 20 | MKNK1 | 1.48278417 |
| 21 | BMPR1B | 1.39585008 |
| 22 | BTK | 1.22992541 |
| 23 | IKBKE | 1.22749524 |
| 24 | CDK3 | 1.20709577 |
| 25 | IKBKB | 1.19077152 |
| 26 | SRPK1 | 1.16310633 |
| 27 | GRK6 | 1.14220427 |
| 28 | SYK | 1.13284321 |
| 29 | ACVR1B | 1.13158216 |
| 30 | PLK4 | 1.12976640 |
| 31 | MYLK | 1.12893376 |
| 32 | MKNK2 | 1.12618862 |
| 33 | MUSK | 1.09989392 |
| 34 | JAK1 | 1.09178512 |
| 35 | MAP4K1 | 1.07657332 |
| 36 | MAP3K6 | 1.04234755 |
| 37 | PIK3CA | 1.01286535 |
| 38 | SIK3 | 0.98656807 |
| 39 | NLK | 0.97948576 |
| 40 | MAP4K2 | 0.97671939 |
| 41 | CSF1R | 0.96240567 |
| 42 | OXSR1 | 0.94208941 |
| 43 | PIM1 | 0.90824648 |
| 44 | CDK8 | 0.90421885 |
| 45 | ITK | 0.83776166 |
| 46 | MAPK13 | 0.81683338 |
| 47 | BLK | 0.81011145 |
| 48 | FGFR3 | 0.80593077 |
| 49 | LYN | 0.79211805 |
| 50 | CSNK1G1 | 0.78551052 |
| 51 | WNK1 | 0.77861805 |
| 52 | YES1 | 0.77013161 |
| 53 | BRD4 | 0.76576441 |
| 54 | PLK2 | 0.72199309 |
| 55 | CDK6 | 0.72178364 |
| 56 | VRK1 | 0.71443253 |
| 57 | MAP2K6 | 0.68123212 |
| 58 | ATR | 0.65182002 |
| 59 | LCK | 0.62793921 |
| 60 | JAK2 | 0.61331755 |
| 61 | MAP2K3 | 0.59936891 |
| 62 | ZAP70 | 0.59418180 |
| 63 | CDK12 | 0.58429844 |
| 64 | CDC7 | 0.57879946 |
| 65 | CSNK1A1L | 0.56052119 |
| 66 | MAPK12 | 0.55985599 |
| 67 | HCK | 0.55694120 |
| 68 | RPS6KA4 | 0.55692929 |
| 69 | FES | 0.55534551 |
| 70 | RPS6KA5 | 0.54884461 |
| 71 | MAPK11 | 0.53583746 |
| 72 | CAMKK2 | 0.53525660 |
| 73 | PHKG2 | 0.52472224 |
| 74 | PHKG1 | 0.52472224 |
| 75 | PRKG1 | 0.51764115 |
| 76 | MAP3K14 | 0.51231446 |
| 77 | STK3 | 0.50064281 |
| 78 | MARK3 | 0.49657583 |
| 79 | RPS6KB2 | 0.48360752 |
| 80 | CCNB1 | 0.47012032 |
| 81 | IRAK1 | 0.46665588 |
| 82 | EGFR | 0.46605638 |
| 83 | ADRBK2 | 0.46088377 |
| 84 | IGF1R | 0.45422967 |
| 85 | CHUK | 0.44337143 |
| 86 | NEK6 | 0.44312945 |
| 87 | AKT3 | 0.42838121 |
| 88 | MAP3K5 | 0.42542209 |
| 89 | ABL1 | 0.41352680 |
| 90 | CSNK1G3 | 0.40505796 |
| 91 | MAPK7 | 0.39597809 |
| 92 | BRSK2 | 0.39183715 |
| 93 | INSRR | 0.38385827 |
| 94 | MAP3K7 | 0.38071025 |
| 95 | JAK3 | 0.36978975 |
| 96 | KDR | 0.36917737 |
| 97 | AURKB | 0.36523296 |
| 98 | ATM | 0.36210106 |
| 99 | PDK2 | 0.36138996 |
| 100 | EIF2AK3 | 0.35252978 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Asthma_Homo sapiens_hsa05310 | 5.57709597 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.26903665 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 4.19906373 |
| 4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 4.02197136 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 4.00907390 |
| 6 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.46078977 |
| 7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.02179581 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 2.56182362 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.41685246 |
| 10 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.29284214 |
| 11 | Viral myocarditis_Homo sapiens_hsa05416 | 2.27282662 |
| 12 | Proteasome_Homo sapiens_hsa03050 | 1.94829260 |
| 13 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.80027527 |
| 14 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.79473974 |
| 15 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.73984008 |
| 16 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.66520912 |
| 17 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.63049380 |
| 18 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.46339088 |
| 19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.44826262 |
| 20 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.39034855 |
| 21 | Platelet activation_Homo sapiens_hsa04611 | 1.36750034 |
| 22 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.33310731 |
| 23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.33119508 |
| 24 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.30083042 |
| 25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.18231660 |
| 26 | Influenza A_Homo sapiens_hsa05164 | 1.16847237 |
| 27 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.15119030 |
| 28 | Circadian rhythm_Homo sapiens_hsa04710 | 1.14034236 |
| 29 | Phototransduction_Homo sapiens_hsa04744 | 1.13262097 |
| 30 | Tuberculosis_Homo sapiens_hsa05152 | 1.08943614 |
| 31 | RNA degradation_Homo sapiens_hsa03018 | 1.08227393 |
| 32 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.99006217 |
| 33 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.93385808 |
| 34 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.88027876 |
| 35 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.80705071 |
| 36 | Homologous recombination_Homo sapiens_hsa03440 | 0.77146358 |
| 37 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.76982023 |
| 38 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.74624973 |
| 39 | Mismatch repair_Homo sapiens_hsa03430 | 0.72761964 |
| 40 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.70573399 |
| 41 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.70120177 |
| 42 | Base excision repair_Homo sapiens_hsa03410 | 0.69255141 |
| 43 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.69059078 |
| 44 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.68347068 |
| 45 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.68336348 |
| 46 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.66242716 |
| 47 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.65660001 |
| 48 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.61738212 |
| 49 | RNA polymerase_Homo sapiens_hsa03020 | 0.61507900 |
| 50 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.61240125 |
| 51 | Salivary secretion_Homo sapiens_hsa04970 | 0.60699177 |
| 52 | Measles_Homo sapiens_hsa05162 | 0.59238638 |
| 53 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.58460700 |
| 54 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.55461538 |
| 55 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.50528040 |
| 56 | RNA transport_Homo sapiens_hsa03013 | 0.49283500 |
| 57 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.49166483 |
| 58 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.47124592 |
| 59 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.46931529 |
| 60 | Olfactory transduction_Homo sapiens_hsa04740 | 0.46261810 |
| 61 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.45799903 |
| 62 | Legionellosis_Homo sapiens_hsa05134 | 0.45248580 |
| 63 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.41774259 |
| 64 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.41763090 |
| 65 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.41734767 |
| 66 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.41045230 |
| 67 | Basal transcription factors_Homo sapiens_hsa03022 | 0.40185121 |
| 68 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.40079871 |
| 69 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.37132082 |
| 70 | Phagosome_Homo sapiens_hsa04145 | 0.36906294 |
| 71 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.36888295 |
| 72 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.35437221 |
| 73 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.35329837 |
| 74 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.34491484 |
| 75 | Pertussis_Homo sapiens_hsa05133 | 0.33767371 |
| 76 | Peroxisome_Homo sapiens_hsa04146 | 0.32843744 |
| 77 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.32293669 |
| 78 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.30684688 |
| 79 | Protein export_Homo sapiens_hsa03060 | 0.29402462 |
| 80 | Taste transduction_Homo sapiens_hsa04742 | 0.29187376 |
| 81 | HTLV-I infection_Homo sapiens_hsa05166 | 0.28412839 |
| 82 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.26716520 |
| 83 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.26218119 |
| 84 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.26068799 |
| 85 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.26056635 |
| 86 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.25552526 |
| 87 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.25039944 |
| 88 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.23492875 |
| 89 | Cell cycle_Homo sapiens_hsa04110 | 0.22984000 |
| 90 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.22867540 |
| 91 | DNA replication_Homo sapiens_hsa03030 | 0.22231795 |
| 92 | Purine metabolism_Homo sapiens_hsa00230 | 0.21780101 |
| 93 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.21733727 |
| 94 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.21547169 |
| 95 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.20999360 |
| 96 | Long-term depression_Homo sapiens_hsa04730 | 0.20741653 |
| 97 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.19266044 |
| 98 | Lysine degradation_Homo sapiens_hsa00310 | 0.19168906 |
| 99 | Alcoholism_Homo sapiens_hsa05034 | 0.18623355 |
| 100 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.18304290 |

